Insurers Post Lackluster Results

Related Link: 

MetLife, Allstate and Hartford Financial reported lackluster operating earnings for the second quarter, in part due to higher storm and catastrophe-related property claims.

Barclays Under U.S. Pressure

Related Link: 

Barclays swung to a net profit in the second quarter but is under renewed pressure in the U.S. after authorities extended a nonprosecution agreement to cover a probe into alleged foreign-exchange manipulation.

Global Firms See Risks in Russia

Related Link: 

U.S. and European companies are girding for the possible impact of tougher international sanctions against Moscow, with auto makers and energy giants moving to limit the Russia risks to their businesses.

Icahn Further Cuts Family Dollar Stake

Related Link: 

Carl Icahn's investor group further trimmed its stake in Family Dollar Stores, two days after the discount retail chain agreed to an $8.5 billion buyout offer from rival Dollar Tree.

Yelp Reports First Profit Since IPO

Related Link: 

Yelp reports its first profit as a public company, but concerns linger about the number of businesses added by the business-review website.

Endurance Specialty Terminates Aspen Offer

Related Link: 

Endurance Specialty Holdings terminated its takeover offer for Aspen Insurance Holdings and abandoned proposals that Aspen's shareholders voted down Friday.

Lions Gate's CEO Paid $63.6 Million

Related Link: 

The CEO of movie studio Lions Gate Entertainment was paid $63.6 million for the fiscal year ended in March, according to a Securities and Exchange filing.

Buyout Shops Look to Rivals for Deals

Related Link: 

Private-equity firms are increasingly buying companies from each other, a shift driven in part by the relative simplicity of completing such an acquisition.

Weight Watchers Earnings Decline, but Full-Year Guidance Increased

Related Link: 

Weight Watchers International Inc. said its second-quarter earnings fell 17% on continued declines in the company's weight-loss meeting attendance, but the company said its transformation "remains on track" and it increased its 2014 earnings guidance.

Allergan Defends Bylaws Amid Effort to Ward Off Valeant

Related Link: 

Allergan is defending corporate bylaws that have emerged as a flash point in its effort to ward off a $53 billion hostile takeover by Valeant Pharmaceuticals.

Syndicate content